{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:49:58Z","timestamp":1759063798763},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI105962","AI107784"],"award-info":[{"award-number":["AI105962","AI107784"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.jim.2016.09.004","type":"journal-article","created":{"date-parts":[[2016,9,19]],"date-time":"2016-09-19T06:17:24Z","timestamp":1474265844000},"page":"1-7","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Detection of herpes simplex virus type 2 (HSV-2) -specific cell-mediated immune responses in guinea pigs during latent HSV-2 genital infection"],"prefix":"10.1016","volume":"439","author":[{"given":"Clarice L.","family":"Perry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brianne N.","family":"Banasik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Summer R.","family":"Gorder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingya","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Auclair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nigel","family":"Bourne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregg N.","family":"Milligan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jim.2016.09.004_bb0005","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.4049\/jimmunol.146.10.3571","article-title":"Cell-mediated immunologic responses and recurrent genital herpes in the guinea pig. Effects of glycoprotein immunotherapy","volume":"146","author":"Bernstein","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.jim.2016.09.004_bb0010","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0166-3542(00)00104-2","article-title":"Pathogenesis of acyclovir-resistant herpes simplex type 2 isolates in animal models of genital herpes: models for antiviral evaluations","volume":"47","author":"Bernstein","year":"2000","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jim.2016.09.004_bb0015","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0166-3542(98)00055-2","article-title":"Effect of undecylenic acid as a topical microbicide against genital herpes infection in mice and guinea pigs","volume":"40","author":"Bourne","year":"1999","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jim.2016.09.004_bb0020","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1086\/498247","article-title":"Impact of immunization with glycoprotein D2\/AS04 on herpes simplex virus type 2 shedding into the genital tract in guinea pigs that become infected","volume":"192","author":"Bourne","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jim.2016.09.004_bb0025","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1099\/0022-1317-83-11-2797","article-title":"Modification of primary and recurrent genital herpes in guinea pigs by passive immunization","volume":"83","author":"Bourne","year":"2002","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jim.2016.09.004_bb0030","first-page":"456","article-title":"Seroprevalence of herpes simplex virus type 2 among persons aged 14-49years\u2013United States, 2005-2008","volume":"59","author":"Centers for Disease and Prevention","year":"2010","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.jim.2016.09.004_bb0035","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.tube.2005.12.001","article-title":"Recombinant guinea pig TNF-alpha enhances antigen-specific type 1T lymphocyte activation in guinea pig splenocytes","volume":"87","author":"Cho","year":"2007","journal-title":"Tuberculosis"},{"key":"10.1016\/j.jim.2016.09.004_bb0040","doi-asserted-by":"crossref","first-page":"7963","DOI":"10.1128\/JVI.74.17.7963-7971.2000","article-title":"Construction, phenotypic analysis, and immunogenicity of a UL5\/UL29 double deletion mutant of herpes simplex virus 2","volume":"74","author":"Da Costa","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.jim.2016.09.004_bb0045","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/jmv.1890360413","article-title":"Outcome of herpes simplex virus type 2 infection in guinea pigs","volume":"36","author":"Fowler","year":"1992","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jim.2016.09.004_bb0050","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1016\/j.vaccine.2014.05.011","article-title":"Development of a novel, guinea pig-specific IFN-gamma ELISPOT assay and characterization of guinea pig cytomegalovirus GP83-specific cellular immune responses following immunization with a modified vaccinia virus Ankara (MVA)-vectored GP83 vaccine","volume":"32","author":"Gillis","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2016.09.004_bb0055","doi-asserted-by":"crossref","first-page":"330","DOI":"10.4269\/ajtmh.2005.72.330","article-title":"Venezuelan equine encephalitis virus in the guinea pig model: evidence for epizootic virulence determinants outside the E2 envelope glycoprotein gene","volume":"72","author":"Greene","year":"2005","journal-title":"Am.J.Trop. Med. Hyg."},{"key":"10.1016\/j.jim.2016.09.004_bb0060","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1086\/315836","article-title":"Interactions between herpes simplex virus type 2 and human immunodeficiency virus type 1 infection in African women: opportunities for intervention","volume":"182","author":"Mbopi-Keou","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jim.2016.09.004_bb0065","doi-asserted-by":"crossref","first-page":"11537","DOI":"10.1128\/JVI.79.17.11537-11540.2005","article-title":"Long-term presence of virus-specific plasma cells in sensory ganglia and spinal cord following intravaginal inoculation of herpes simplex virus type 2","volume":"79","author":"Milligan","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.jim.2016.09.004_bb0070","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.biologicals.2014.01.002","article-title":"Immunological evaluation of mannosylated chitosan nanoparticles based foot and mouth disease virus DNA vaccine, pVAC FMDV VP1-OmpA in guinea pigs","volume":"42","author":"Nanda","year":"2014","journal-title":"Biologicals"},{"key":"10.1016\/j.jim.2016.09.004_bb0075","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jri.2011.01.013","article-title":"Rapid clearance of herpes simplex virus type 2 by CD8+ T cells requires high level expression of effector T cell functions","volume":"89","author":"Nelson","year":"2011","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.jim.2016.09.004_bb0080","first-page":"324","article-title":"The guinea pig as a model of infectious diseases","volume":"58","author":"Padilla-Carlin","year":"2008","journal-title":"Comp. Med."},{"key":"10.1016\/j.jim.2016.09.004_bb0085","first-page":"927","article-title":"Pathogenesis of endometritis and salpingitis in a guinea pig model of chlamydial genital infection","volume":"140","author":"Rank","year":"1992","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jim.2016.09.004_bb0090","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jim.2007.08.012","article-title":"Monoclonal antibodies to guinea pig interferon-gamma: tools for cytokine detection and neutralization","volume":"328","author":"Schafer","year":"2007","journal-title":"J. Immunol. Methods"},{"issue":"Suppl 2","key":"10.1016\/j.jim.2016.09.004_bb0095","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/S1386-6532(02)00100-2","article-title":"Animal models of congenital cytomegalovirus infection: an overview of progress in the characterization of guinea pig cytomegalovirus (GPCMV)","volume":"25","author":"Schleiss","year":"2002","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jim.2016.09.004_bb0100","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1016\/j.vaccine.2010.04.077","article-title":"TC83 replicon vectored vaccine provides protection against Junin virus in guinea pigs","volume":"28","author":"Seregin","year":"2010","journal-title":"Vaccine"},{"issue":"Suppl 11","key":"10.1016\/j.jim.2016.09.004_bb0105","doi-asserted-by":"crossref","first-page":"S920","DOI":"10.1093\/clind\/13.Supplement_11.S920","article-title":"Evaluation of herpes simplex virus vaccines in animals: the guinea pig vaginal model","volume":"13","author":"Stanberry","year":"1991","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.jim.2016.09.004_bb0110","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.biologicals.2015.09.004","article-title":"Comparative efficacy of virus like particle (VLP) vaccine of foot-and-mouth-disease virus (FMDV) type O adjuvanted with poly I:C or CpG in guinea pigs","volume":"43","author":"Terhuja","year":"2015","journal-title":"Biologicals"},{"key":"10.1016\/j.jim.2016.09.004_bb0115","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/978-1-62703-484-5_24","article-title":"In vivo evaluation of antiviral efficacy against genital herpes using mouse and guinea pig models","volume":"1030","author":"Valencia","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jim.2016.09.004_bb0120","doi-asserted-by":"crossref","first-page":"7046","DOI":"10.1016\/j.vaccine.2012.09.057","article-title":"A Vaxfectin((R))-adjuvanted HSV-2 plasmid DNA vaccine is effective for prophylactic and therapeutic use in the guinea pig model of genital herpes","volume":"30","author":"Veselenak","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2016.09.004_bb0125","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.tube.2009.08.004","article-title":"Evaluation of new vaccines for tuberculosis in the guinea pig model","volume":"89","author":"Williams","year":"2009","journal-title":"Tuberculosis"},{"key":"10.1016\/j.jim.2016.09.004_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114652","article-title":"Virus-specific immune memory at peripheral sites of herpes simplex virus type 2 (HSV-2) infection in guinea pigs","volume":"9","author":"Xia","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jim.2016.09.004_bb0135","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.4161\/hv.36084","article-title":"HPV16L1-attenuated Shigella recombinant vaccine induced strong vaginal and systemic immune responses in guinea pig model","volume":"10","author":"Yan","year":"2014","journal-title":"Hum. Vaccin. Immunother."}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175916302010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175916302010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T05:05:09Z","timestamp":1692507909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175916302010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":27,"alternative-id":["S0022175916302010"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2016.09.004","relation":{},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detection of herpes simplex virus type 2 (HSV-2) -specific cell-mediated immune responses in guinea pigs during latent HSV-2 genital infection","name":"articletitle","label":"Article Title"},{"value":"Journal of Immunological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jim.2016.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}